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 The neurochemical changes occurring between the preweanling period 
and adolescence could be crucial for understanding the role development plays 
in the manifestation of psychotic behaviors. N-ethoxycarbonyl-2-ethoxy-1,2-
dihydroquinoline (EEDQ) fully attenuates the DA agonist-induced behaviors of 
adult rats, while potentiating the DA agonist-induced locomotor activity of 
preweanling rats. My specific hypotheses were as follows: (1) Systemically 
administered EEDQ would block the cocaine-induced locomotor activity of adult 
rats. (2) Systemically administered EEDQ would potentiate the cocaine-induced 
locomotion of preweanling rats. (3) EEDQ would increase the Emax values (a 
measure of D2 receptor sensitivity) of preweanling rats, but not adolescent or 
adult rats. And, (4) EEDQ would reduce dorsal striatal β-arrestin-2 (ARRB2) and 
GRK6 levels (measures of D2 receptor sensitivity) of preweanling rats. 
Behavioral results were as expected, because EEDQ attenuated the locomotion 
of adult and adolescent rats, while EEDQ potentiated locomotor activity of 
preweanling rats. EEDQ enhanced the GTPγS binding of preweanling rats, while 
depressing ARRB2 levels. These results are consistent with the overarching 
hypothesis that EEDQ causes DA supersensitivity in preweanling rats. Thus, it is 
here proposed that EEDQ inactivates a significant number of D2 receptors in 
preweanling rats, but that the remaining D2 receptors are supersensitive and 




I would like to thank my advisor, Dr. McDougall, for his guidance, 
patience, and support while completing this project. I would also like to thank Dr. 
Crawford and Dr. Amodeo for their input. Lastly, and most importantly, thank you 




TABLE OF CONTENTS 
ABSTRACT .......................................................................................................... iii 
ACKNOWLEDGEMENTS .....................................................................................iv 
LIST OF TABLES ............................................................................................. viiiii 
LIST OF FIGURES ............................................................................................ ixiii 
CHAPTER ONE: INTRODUCTION…………………………………………………...1  
CHAPTER TWO: DOPAMINE MEDIATED BEHAVIORS IN ADULT RATS  
Behavioral Effects of Direct D1 Receptor Agonists…………………………2 
Behavioral Effects of Direct D2 Receptor Agonists…………………………2 
Effects of Combined Direct D1 and D2 Receptor Stimulation………...……3                                                                            
 Behavioral Effects of Indirect DA Agonist………………………………..…..3  
Behavioral Effects of Direct D1 Receptor Antagonist………………….……4      
Behavioral Effects of Direct D2 Receptor Antagonist…………………….....5                                                                               
CHAPTER THREE: DOPAMINE-MEDIATED BEHAVIORS IN RAT PUPS 
Behavioral Effects of Direct D1 Receptor Agonists…………………….……6 
Behavioral Effects of Direct D2 Receptor Agonists…………………….……7 
Effects of Combined Direct D1 and D2 Receptor Stimulation………...……7  
Indirect DA Agonist-Induced Behavior…………………………………..……8  
Behavioral Effects of Direct D1 Receptor Antagonists………………...……8  
Behavioral Effects of Direct D2 Receptor Antagonists………………...……9  
Summary…………………………………………………………………………9 




  Storage and Release……..………………………………………………..….10 
 Reuptake ………………………………………………………………………10  
Receptors……………………………………………………………………….11  
Presynaptic vs. Postsynaptic Receptors…………………………………….11  
Major Dopamine Pathways in the Basal Ganglia……………………..……12  
Intrinsic Non-Dopaminergic Pathways in the Basal Ganglia………...……12  
CHAPTER FIVE: DOPAMINE PHARMACOLOGY: DEVELOPMENT …….……14 
CHAPTER SIX: EEDQ ………………………………………………………….……17 
CHAPTER SEVEN: SUMMARY AND HYPOTHESIS ……………………….……21 
CHAPTER EIGHT: METHODS  
Subjects ………………………………………………………………………..23  
Apparatus…………………………………………………………………….…23  
Drugs……………………………………………………………………………24  
Behavioral Procedure…………………………………………………………24  
Homogenate [35S] GTPγS Binding Assay……...………………………..….24  
ARRB2 and GRK6……………………………………………………………..26  
Statistics Analysis…………………………………………………………..….27  
CHAPTER NINE: BEHAVORIAL RESULTS  
            Overall Analysis……………………………………………………………....28 
 
           Ontogenetic Differences in the Locomotor Activity of Male Rats (Collapsed  
           Over Time Blocks)……..………………………………………………………28 
 
           Ontogenetic Differences in the Locomotor Activity of Male Rats (Time- 
vii 
 
           Dependent Effects)………….……….……………………………………….29 
 
           Ontogenetic Differences in the Locomotor Activity of Female Rats 
(Collapsed Over Time Blocks)…….………….………………………………………31 
 
           Ontogenetic Differences in the Locomotor Activity of Female Rats (Time- 
           Dependent Effects)………….…………..………………………………….…32 
 
            [35S]GTPγS Binding….…………..…………………………………………...34 
 
            ARRB2 Levels……..………………………………………………….………34 
 
            GRK6 Levels…………………………………………………………………..34  
 
CHAPTER TEN: DISCUSSION 
           Behavioral Effects of EEDQ…………...……………………………………..43 
           Age-Dependent Behavioral Differences…………………………………….43 
           Neurochemistry Results Pertaining to DA Supersensitivity……………….45 
           Explanations of EEDQ-Induced Locomotor Potentiation in Preweanling  
           Rats……..………………………………………………………………...….…46 
            Differential Effects of EEDQ on Cocaine- and Amphetamine-Induced  
            Locomotor Activity…………………………………………………………....48 
            Ontogeny of Drug Action……………………………………………………..49 
              Sex-Dependent Behavioral Differences…………………………………..50 











LIST OF TABLES 
 
Table 1. Mean (SEM) Efficacy (Emax) of NPA-Stimulated [35S]GTPγS Specific 
Binding in the Dorsal Striatum of EEDQ-Treated Preweanling, Adolescent, and 
Adult Rats………………………………………………………………………..…......39 
 
Table 2.  Mean (SEM) Potency (pEC50) of NPA-Stimulated [35S]GTPγS      
Specific Binding in the Dorsal Striatum of EEDQ-Treated Preweanling, 
Adolescent, and Adult Rats……………………………………………………...…...40 
 
Table 3.  Mean (SEM) -Arrestin Levels (pg/mg protein) in the Dorsal Striatum   
of EEDQ-Treated Preweanling, Adolescent, and Adult Rats …………………….41 
 
Table 4. Mean (SEM) GRK6 Levels (pg/mg protein) in the Dorsal Striatum of 


















LIST OF FIGURES 
Figure 1. Ontogenetic Differences in the Locomotor Activity of Male Rats 
(Collapsed Over Time Blocks)…………………………………………………..……35 
 
Figure 2. Ontogenetic Differences in the Locomotor Activity of Male Rats (Time-
Dependent Effects)……………..………………………………………………..……36  
 
Figure 3. Ontogenetic Differences in the Locomotor Activity of Female Rats 
(Collapsed Over Time Blocks)…………………………………………………..……37   
 
Figure 4.  Ontogenetic Differences in the Locomotor Activity of Female Rats 









 The dopamine (DA) system primarily mediates motor movement, 
cognition, and emotional behavior (Keeler, Pretsell, & Robbins, 2014). Activation 
of the DA system causes distinct actions depending on which receptors are 
targeted. For example, under- or over-stimulation of D1 receptors results in mood 
and cognitive impairments (Avery & Krichmar, 2015); whereas, overproduction of 
D2 receptors in the nucleus accumbens (NAc) may cause psychotic behaviors to 
emerge (Yoon, Minzenberg, Raouf, D’Esposito, & Carter, 2013). D3 receptors, 
which are preferentially found in the hypothalamus, limbic areas, substantia 
nigra, and the ventral tegmental area (Stahl, 2017), regulate cognition, mood, 
and motivation, and are responsible for schizophrenic-like symptoms (Maramai, 
et al., 2017).  In addition, Parkinson’s disease results from a loss of DA 
containing neurons in the nigrostriatal pathway (Graumann et al., 2002). Thus, 
studying DA receptors is crucial for understanding neuropsychiatric disorders 








            CHAPTER TWO 
DOPAMINE MEDIATED BEHAVIORS IN ADULT RATS  
Behavioral Effects of Direct D1 Receptor Agonists 
 Agonist and antagonist drugs are useful tools for understanding the role 
DA receptor subtypes play in behavior (Keeler et al., 2014).  For example, 
systemic administration of the partial D1 receptor agonist, SKF 38393, induces 
oral movements, grooming and locomotor activity in adult rats and mice (Desai, 
Terry, & Katz, 2005; Neisewander, Ong, & McGonigle, 1995). Administration of 
the full D1 receptor agonist SKF 82958 also increases locomotor activity in adult 
rats (Charntikov et al., 2011). The anatomical locus of these effects includes the 
NAc, because microinjecting SKF 38393 into this structure induces locomotor 
activity in adult rats (Charntikov et al., 2011; Meyer, 1993; Neisewander et al., 
1995).  
Behavioral Effects of Direct D2 Receptor Agonists 
 Systemic administration of selective D2 receptor agonists, such as 
quinpirole or bromocriptine, typically increases locomotion in rats and mice 
(Hoffman & Wise, 1992; Wise & Carlezon, 1994); however, treatment with low 
doses of a direct D2 receptor agonist actually inhibits locomotor activity 
(Bradbury, Cannon, Costall, & Naylor, 1984). The reason for this biphasic effect 
is interesting, since low doses of quinpirole stimulate autoreceptors, thereby 
reducing DA synthesis and/or release and, as a consequence, decrease 
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locomotor activity (Eilam, Golani, & Szechtman, 1989). At high doses, quinpirole 
directly stimulates postsynaptic receptors and produces locomotor activity (Eilam 
& Szechtman, 1989; Neisewander et al., 1995). 
Effects of Combined Direct D1 and D2 Receptor Stimulation 
 Although stimulating D1 or D2 receptors alone induces locomotor activity 
and other behaviors, combined stimulation of D1 and D2 receptors causes a 
unique pattern of behavior (for a review, see Arnt, 1987). For example, systemic 
administration of both SKF 38393 and quinpirole, at low doses, induces 
locomotor activity and some rearing behaviors (Ikemoto, 2002).  At high doses, 
co-administration of SKF 39383 and quinpirole causes more intense behaviors, 
including head-down sniffing, gnawing, biting, and other stereotypies (Ikemoto, 
2002). Microinjecting both D1 and D2 agonists into the caudate-putamen (CPu) 
induces intense stereotypies, but no locomotion (Bordi & Meller, 1989; Breese et 
al., 1987; Waszczak, Martin, Finlay, Zahr, & Stellar, 2002).  
Behavioral Effects of Indirect DA Agonists 
 D1 and D2 receptors play an important role in the locomotor activating 
effects of psychomotor stimulants, such as cocaine and amphetamine (Barret, 
Miller, Dohrmann, & Caine, 2004; Cabib, Castellano, Cestari, Filibeck, & Puglisi-
Alegra, 1991; Dias, Carey, & Carrera, 2006). When cocaine is acutely 
administered, DA transporters located on the presynaptic membrane are 
inhibited, which results in an excess of DA in the synaptic cleft (Cabib et al., 
 4 
1991; Henry, Hu, & White, 1998). This excess DA stimulates D1 and D2 
receptors and induces behavioral effects. When administered at low to moderate 
doses, cocaine increases the locomotor activity of adult rats (Kita, Shiratani, 
Takenouchi, Fukuzako, & Takigawa, 1999). Not surprisingly, when administered 
at high doses, cocaine causes intense stereotypies (Kita et al., 1999). Although 
sometimes working through different mechanisms (e.g., altering DA release 
characteristics), other psychomotor stimulants (e.g., amphetamine) also stimulate 
locomotor activity and stereotypies by increasing extracellular DA levels (Wise & 
Carlezon, 1994). 
Behavioral Effects of Direct D1 Receptor Antagonists 
 Systemic administration of SCH 23390 blocks quinpirole-induced 
behaviors like sniffing, yawning, and locomotor activity (McDougall, Crawford, & 
Nonneman, 1992). The fact that a D1 receptor antagonist (SCH 23390) blocks 
the behavioral effects of a D2 receptor agonist (quinpirole) suggests that 
stimulation of the D1 receptor is crucial for the expression of D2 receptor-
mediated behaviors (Delfs & Kelley, 1990).  Some of these effects are mediated 
by the NAc, since microinjecting SCH 23390 into the NAc significantly reduces 
the behavioral effects of quinpirole (Bordi & Meller, 1989). Likewise, infusing 
SCH 23390 into the ventral lateral striatum decreases the oral behaviors, but not 
the locomotor activity, of amphetamine-treated rats (Delfs & Kelley, 1990). The 
latter result suggests that D1 and D2 receptors in the ventral lateral striatum 
mediate stereotypy and not locomotion. 
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Behavioral Effects of Direct D2 Receptor Antagonists 
 Not surprisingly, D2 receptor antagonists block the behavioral effects 
caused by a D2 receptor agonist. For example, systemic administration of 
sulpride significantly reduces the behavioral effects caused by microinjecting 
quinpirole into the NAc (Bordi & Meller, 1989; McDougall et al., 1992). Systemic 
treatment with a D2 antagonist also blocks the grooming behavior caused by 
SKF 39393 administration (McDougall et al., 1992). Thus, a functional D2 system 































DOPAMINE-MEDIATED BEHAVIORS IN RAT PUPS 
 
 Changes in catecholamine levels lead to a higher probability of psychiatric 
disorders, addiction, and motoric problems (Antonopoulos, Dori, Dinopoulos, 
Chiotelli, & Parnavelas, 2002). For example, early exposure to psychostimulant 
drugs can promote drug addiction in adulthood due to chemical changes 
occurring at a younger postnatal age. Byrnes and Bruno (1994) suggest that 
early cocaine exposure activates compensatory mechanisms that persist into 
adulthood and lead to addiction. In the developing brain, DA also plays a crucial 
role in mediating sensory motor information, such as locomotor activity and 
stereotypy. Drugs that act as agonists and antagonists allow us to determine DA 
receptor function, while microinjection techniques allow us to examine the locus 
of drug effects. 
Behavioral Effects of Direct D1 Receptor Agonists 
 Systemic administration of SKF 38393, a partial D1 receptor agonist, 
increases probing, head lifting, and locomotion in rats at postnatal day (PD) 3 
through PD 10 (Moody & Spear, 1992). At PD 20, SKF 38393 enhances 
grooming, oral movements, and locomotor activity (McDougall et al., 1992). 
Microinjecting the full D1 receptor agonist SKF 82958 directly into the CPu 
increases both locomotor activity and stereotypy in preweanling rats (Charntikov 
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et al., 2011). Lower doses of SKF 82958 preferentially induce locomotor activity, 
whereas higher doses increase stereotypic behaviors (Charntikov et al., 2011).  
Behavioral Effects of Direct D2 Receptor Agonists 
 Systemic administration of quinpirole, a selective D2 agonist, increases 
locomotor activity, yawning, sniffing, and rearing during the preweanling period 
(McDougall et al., 1992). For example, quinpirole produces forward locomotion 
by as early as PD 3, and even greater amounts of locomotor activity at PD 10 
and PD 21 (Moody & Spear, 1992). Although selective D2 receptor agonists 
increase locomotor activity, oral movements are inhibited by quinpirole (Der-
Ghazarian et al., 2012). While most of these effects mimic what occurs in adults, 
D2 receptor agonists can sometimes function as antagonists in preweanling rats, 
but only during conditions of low dopaminergic tone (Byrnes & Bruno, 1994; 
Yoshida, Baella, Stuebner, Crawford, & McDougall, 2006).   
Effects of Combined Direct D1 and D2 Receptor Stimulation 
 During early ontogeny, systemic administration of NPA, a non-selective 
D1/D2 receptor agonist, typically enhances stereotypy and decreases grooming, 
but these effects are highly dependent on dose and age (McDougall et al., 1992). 
At moderate doses of NPA, co-stimulation of D1 and D2 receptors increases 
nonstereotypic behaviors in PD 10 pups, such as wall climbing, roll curling, and 
forward locomotion (McDougall et al., 1992). At PD 17 and PD 20, rats also show 
increased locomotion after moderate doses of NPA (Der-Ghazarian et al., 2012).  
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In adult rats, locomotion is replaced by stereotypy when moderate or high doses 
of NPA are administered (Bordi, Carr, & Meller, 1989). 
Indirect DA Agonist-Induced Behavior 
 Psychomotor stimulants, such as cocaine and amphetamine, cause an 
increase in locomotor activity in young rats (Anker & Carroll, 2010). Cocaine 
sensitivity is higher in preweanling rats (PD 5 and PD 20) than adults, perhaps 
due to a greater percentage of D2High receptors in the striatum (McDougall, 
Eaton, Mohd-Yusof, & Crawford, 2015). Sensitivity to cocaine begins to drop 
during adolescence, as the percentage of D2High receptors gradually declines to 
adult-like levels (McDougall et al., 2015).  
Behavioral Effects of Direct D1 Receptor Antagonists 
 Systemic administration of SCH 23390, a D1 receptor antagonist, blocks 
the behavioral effects of the D1 receptor agonist SKF 38393 in preweanling rats 
(Charntikov et al., 2011). Systemic administration of SCH 23390 also blocks 
quinpirole-induced behaviors, such as sniffing, yawning, and locomotor activity 
(Chausmer & Katz, 2002; Moody & Spear, 1992; Sobrian, Jones, Varghese, & 
Holson, 2003), thus showing that in both preweanling and adults rats a functional 
D1 receptor system is necessary for the expression of D2-mediated behaviors. 
SCH 23390 also attenuates cocaine-induced behavioral effects in preweanling 
rats (Charntikov et al., 2011). These actions may be mediated by the CPu, since 
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microinjecting SCH 23390 into the CPu significantly reduces the behavioral 
impact of quinpirole in preweanling rats (Charntikov et al., 2011).  
Behavioral Effects of Direct D2 Receptor Antagonists 
 Systemic administration of a D2 receptor antagonist (e.g., raclopride) 
blocks the behavioral effects of a D2 receptor agonist (e.g., quinpirole) in 
preweanling rats (Charntikov et al., 2011). Systemic administration of a D2 
receptor antagonist also blocks the locomotor activity caused by D1 receptor 
agonists or cocaine (Byrnes & Bruno, 1994; Chausmer & Katz, 2002; McDougall 
et al., 1992). On PD 18, microinjecting SKF 82958 and quinpirole directly into the 
CPu increase locomotion, head down sniffing, and repetitive motor movement, 
while infusing raclopride into the CPu fully attenuates these agonist-induced 
behavioral effects (Charntikov et al., 2011). 
Summary 
 In preweanling rats, D1 and D2 receptors interact when mediating 
unlearned behaviors.  For example, D1 receptors are necessary for the full 
expression of D2-mediated locomotor activity, whereas a functional D2 receptor 
system is necessary for the full expression of D1-mediated behaviors 
(McDougall, Arnold, & Nonneman, 1990). This conclusion is not surprising since 
a similar relationship exists between D1 and D2 receptor systems in adult rats 







 DA, norepinephrine (NE) and epinephrine are all part of a monoamine 
subfamily called the catecholamines. The rate-limiting step in the production of 
the catecholamines is tyrosine hydroxylase. Tyrosine hydroxylase converts 
tyrosine into levopoda (L-DOPA). L-DOPA is then converted into the 
neurotransmitter DA by the enzyme dopa decarboxylase (Ugrumov, 2006).  
Storage and Release 
 
 DA is stored in vesicles in the presynaptic terminal. DA exocytosis is 
triggered by an influx of Ca2+, whereby vesicles fuse to the membrane wall and 
release DA into the synaptic cleft (Cooper, Bloom, & Roth, 2003). 
Reuptake  
 
 Free DA in the synaptic cleft is returned to the presynaptic terminal via an 
ATP-dependent DA reuptake transporter (DAT) (Zanettini et al., 2018). This free-
floating DA is then repackaged in vesicles for reuse. Excess DA in the 





 DA receptors are classified into the D1 and D2 family of receptors. The D1 
family includes D1 and D5 receptors, whereas the D2 family of receptors contains 
the D2, D3, and D4 subtypes (Cooper et al., 2003). Stimulating the D1 family of 
receptors activates the enzyme adenylyl cyclase, which increases cyclic 
adenosine monophosphate (c-AMP) levels (Cooper et al., 2003). Conversely, 
stimulating the D2 family of receptors inhibits adenylyl cyclase and reduces 
cAMP, thereby modulating the phosphorylation of K+ channels and inhibiting 
Ca2+ channels (Ogren, Hall, Kohler, Magnusson, & Sjostrand, 1986).   
 DA receptors exist in high and low affinity states. For example, DA 
sensitivity is associated with the proportion of D2 receptors in a high affinity state 
(Seeman, 2008). Work by Seeman et al. (2005) suggests that an excess of 
D2High receptors produces DA supersensitivity, which can cause DA agonists to 
have an exaggerated behavioral response. An excess of D2High receptors may be 
responsible for many neuropsychiatric disorders, including psychosis and drug 
addiction (Seeman et al., 2005). 
Presynaptic vs. Postsynaptic Receptors  
 
 In addition to the various receptor subtypes, DA receptors can be 
differentiated according to whether they are located postsynaptically or 
presynaptically. DA postsynaptic receptors are G protein-coupled receptors that 
alter K+ permeability (Onali, Mosca, & Olianas, 1992). For example, stimulation of 
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postsynaptic D1 receptors causes IPSP’s in the down-stream neuron (Onali et 
al., 1992). In contrast, stimulation of presynaptic D2 autoreceptors decreases DA 
synthesis and release through G protein-mediated mechanisms (Onali et al., 
1992). 
Major Dopamine Pathways in the Basal Ganglia 
 The ventral tegmental area (VTA) is part of a motivational pathway 
projecting to various brain areas, such as the NAcc, hypothalamus, hippocampus 
and neocortex (Antonopoulos et al., 2001). The substantia nigra pars compacta 
(SNPC) is the starting point of another ascending pathway projecting to the CPu. 
Neurons projecting from the VTA and SNPC release DA at their target locations. 
Thus, stereotypy and motor movement are partially mediated by the nigrostriatal 
DA pathway projecting from the SNPC to the CPu (Bordi & Meller, 1989; Delfs & 
Kelley, 1990); whereas, locomotion, motivation and reward are partially mediated 
by the mesolimbic DA pathway projecting from the VTA to the NAcc and cortical 
structures (Delfs, Schreiber, & Kelley, 1990; Gong, Neil, & Justice, 1996; Meyer, 
Van Hartesveldt, & Potter, 1993)  
Intrinsic Non-Dopaminergic Pathways in the Basal Ganglia 
 
 There are two pathways interconnecting the structures of the basal 
ganglia: the direct pathway and the indirect pathway (for reviews, see Alexander, 
DeLong, & Strick, 1986; Parent & Hazrati, 1995a,1995b). The direct pathway is 
formed from long axonal projections going from the CPu to the globus pallidus 
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internal segment (GPi) and substantia nigra pars reticulata (SNRP). The indirect 
pathway is comprised of a series of neurons projecting from the CPu to the 
globus pallidus external segment (GPe), to the subthalamic nucleus, and 
terminating at the GPi and SNPR. The direct pathway facilitates locomotor 
activity, reward, and reinforcement, while the indirect pathway suppresses the 



















DOPAMINE PHARMACOLOGY: DEVELOPMENT  
 DA acts on D1-like and D2-like receptors to regulate motor and non-motor 
functions (Mishra, Singh, & Shukla, 2018). Both D1 and D2 receptors must be 
fully functional in order to express DA-mediated behaviors (Grigoriadis et al., 
1996). As mentioned above, DA receptors are found both pre- and 
postsynaptically, and become functionally mature at different stages of 
development (Grigoriadis et al., 1996; Hedner & Lundborg, 1985; Parish, 
Finklestein, Drago, Borrelli, & Horne, 2001).  Presynaptic DA receptors are not 
present at PD 4 and do not become fully mature and functional until PD 28 
(Grigoriadis et al., 1996; Hedner & Lundborg, 1985). More specifically, PPP, 
which is a DA agonist that preferentially binds to autoreceptors, increases 
locomotor activity at PD 4 but decreases locomotion at PD 28, thus indicating 
that only postsynaptic receptors are functional at the earlier age. Indeed, D2 
autoreceptors are not fully functional until the 4th postnatal week, but are 
neurochemically available by PD 17 (Lin & Walters, 1994).  
  In terms of postsynaptic D1 and D2 receptors, there is a progressive 
increase in the availability of striatal D1 and D2 receptors from birth through the 
preweanling period (Kuperstein, Eilam, & Yavin, 2008; McDougall et al., 2014; 
Rao, Molinoff, & Joyce, 1991; Teicher, Anderson, & Hostetter, 1995). During 
adolescence, there is an overproduction of D1 and D2 receptors, which gradually 
declines as rats enter adulthood (Andersen, 2003; McDougall et al., 2015). 
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 In addition to these receptor changes, other DA elements develop across 
early ontogeny, including DAT, VMAT2, DA content, tyrosine hydroxylase 
activity, adenylyl cyclase activity, and D1 and D2 receptor activity (Broaddus & 
Bennett, 1990; Giorgi et al.,1987; Kuperstein et al., 2008; Tarazi & Baldessarini, 
2000). Work done by Kuperstein et al. (2008), showed that there is a linear 
increase in tyrosine hydroxylase levels in the substantia nigra across ontogeny. 
VMAT2, DAT content, and DA levels in the CPu also exhibit a linear increase 
from PD 0 to PD 30 (Kuperstein et al., 2008). The ontogeny of adenylyl cyclase is 
similar to the ontogeny of D1 receptors, as adenylyl cyclase activity gradually 
increases across the preweanling period and into adolescence, and then 
gradually declines into adulthood (Broaddus & Bennett, 1990).  
 As mentioned before, DA receptor numbers increase across the 
preweanling period, peak in adolescence, and gradually decline into adulthood 
(Andersen, 2003). In terms of neuronal functionality, the ontogeny of nigrostriatal 
DA neurons has been examined using single-unit extracellular 
electrophysiological methods. Although the basal discharge rate, conduction 
velocity, and firing pattern of nigrostriatal neurons of 4- and 5-week-old rats was 
similar to adults, 2-week-old-rats differed significantly in all three of these 
physiological characteristics (Freeman, 2008). Specifically, the conduction 
velocity and basal discharge rate of nigrostriatal neurons were significantly 
reduced in 14-day-old rats when compared to adults. Thus, Freeman (2008) 
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concluded that physiological properties of nigrostriatal DA neurons are in a 














































  N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) is an irreversible 
DA receptor antagonist that permanently inactivates DA receptors. EEDQ is 
typically used to study the time course of DA receptor replacement (Crawford, 
McDougall, Rowlett, & Bardo, 1992; Crawford, Rowlett, McDougall, & Bardo, 
1994), but EEDQ can also be used to examine the role of DA receptors in 
behavior (Meller, Bordi, & Bohmarker, 1989). Although EEDQ affects a variety of 
receptor types, specificity can be attained by preinjecting rats with reversible 
selective DA antagonists (e.g., raclopride on SCH 23390) before EEDQ 
treatment. In this way, D1 or D2 receptors can be selectively protected from 
EEDQ-induced inactivation (Cameron & Crocker, 1989; Giorgi & Biggio, 1990; 
Meller, Bohmaker, Goldstein, & Friedhoff, 1985).  
 Importantly, EEDQ produces dramatically different behavioral effects in 
preweanling and adult rats (McDougall et al., 1992; McDougall, Crawford, & 
Nonneman, 1993). In adult rats, EEDQ eliminates DA agonist-induced behaviors. 
For example, EEDQ fully attenuated the NPA-induced locomotor activity of adult 
rats when measured one or two days after EEDQ administration (McDougall et 
al., 1992; Meller et al., 1989). Similarly, EEDQ abolishes apomorphine-induced 
stereotypies and quinpirole-induced rotational behavior in adult rats (Cameron & 
Crocker, 1989; Giorgi & Biggio, 1990). DA agonist-induced behaviors began to 
re-emerge when assessed four or more days after EEDQ treatment (Meller et al., 
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1989).  
 In complete contrast, EEDQ does not block the DA agonist-induced 
locomotor activity of preweanling rats. For example, pretreating 17-day-old rats 
with EEDQ did not attenuate the acute locomotor activating effects of NPA 
(McDougall et al., 1992; 1993). Indeed, EEDQ often potentiates the D2 agonist-
induced locomotor activity of younger animals. In preweanling rats, infusing NPA, 
quinpirole, or cocaine into the CPu actually stimulates greater amounts of 
locomotor activity in EEDQ-pretreated rats than controls (Der-Ghazarian et al., 
2012, 2014). Studies using selective DA agonists, as well as D1 and D2 receptor 
protection, have shown that the D2 receptor is responsible for EEDQ’s age-
dependent behavioral effects (Der-Ghazarian et al., 2014). Thus, inactivating DA 
receptors with EEDQ cause a paradoxical potentiation of D2 agonist-induced 
locomotor activity in preweanling rats, while EEDQ blocks the DA agonist-
induced behaviors of adult rats.  
 The reason for EEDQ’s surprising age-dependent behavior effects is 
uncertain. The most obvious possibility is that EEDQ does not cause DA receptor 
loss in preweanling rats. This explanation is not correct because systemic 
administration of EEDQ (7.5 mg/kg) causes a substantial decline (preweanling 
47%; adult 40%) in the D2 receptors of both age groups (McDougall et al., 2014). 
When microinjected into the CPu, EEDQ causes significantly greater reductions 
in the D2 receptors of preweanling rats (54%) than adult rats (35%) (Der-
Ghazarian et al., 2012). Regardless, it is clear that EEDQ’s ability to potentiate 
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the DA agonist-induced behaviors of preweanling rats cannot be explained by 
slight differences in the total amount of DA receptor inactivation.  
 Another possible explanation for EEDQ’s paradoxical behavioral effects is 
the presence of a large D2 receptor reserve in young rats. In other words, 
preweanling rats may possess a large excess of unused DA receptors, thus a 
50% reduction of D2 receptors, for example, would be insufficient to impact 
behavior. Such a D2 receptor reserve does exist in adult rats (Meller, Bohmaker, 
Namba, Friedhoff, & Goldstein, 1987; Meller et al., 1985; Rosengarten, 
Schweitzer, & Friedhoff, 1989), but there is no evidence for such a reserve in 
preweanling rats. For example, D2 receptors in the CPu show a linear increase 
across the preweanling period and into adolescence (Rao et al., 1991), thus 
leaving little room for a receptor reserve. 
 A third possible explanation is that the DA receptors remaining after 
EEDQ-induced inactivation exist in a high affinity state, and that these high 
affinity D2 receptors are significantly more prevalent in preweanling rats than 
adult rats. If true, these excess D2High receptors could be responsible for the 
potentiated locomotor response observed in preweanling rats (McDougall et al., 
2014). Indeed, DA supersensitivity typically occurs when there is an increase in 
the percentage of D2High receptors (Seeman et al., 2005). To examine the effects 
of EEDQ on high affinity D2 receptors, McDougall et al. (2014) measured the 
D2High receptors of preweanling, adolescent, and adult rats one day after vehicle 
or EEDQ (7.5 mg/kg) pretreatment. As hypothesized, the percentage of D2High 
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receptors in the CPu was significantly greater in EEDQ-treated preweanling rats 
than adults. Therefore, this receptor binding data is consistent with the 
hypothesis that EEDQ’s ability to potentiate DA agonist-induced behaviors is due 
to an excess of D2High receptors.  




































SUMMARY AND HYPOTHESES  
 In summary, EEDQ fully attenuates the DA agonist-induced behaviors of 
adult rats. Surprisingly, preweanling rats do not respond to EEDQ in the same 
manner as adult rats, because EEDQ either potentiates or does not affect the DA 
agonist-induced behaviors of preweanling rats. The neurochemical changes that 
occur between the preweanling period and adolescence could be crucial to 
understanding the role of development in the manifestation of psychotic 
behaviors.   
 There are a number of explanations for EEDQ’s age-dependent 
paradoxical actions. For example, EEDQ may not reduce the DA receptor levels 
of preweanling rats and/or preweanling rats may possess a large D2 receptor 
reserve. There is little evidence for these possibilities. Alternatively, EEDQ may 
cause a relative increase in the percentage of D2High receptors in preweanling 
rats when compared to adults. Such an effect has been observed before 
(McDougall et al., 2014), but it is uncertain whether this EEDQ-induced increase 
in the percentage of D2High receptors is actually capable of mediating behavioral 
or neurochemical effects. The purpose of this thesis was to more fully examine 
the latter issue. 
 My specific hypotheses were as follows: (1) Systemically administered 
EEDQ would block the cocaine-induced locomotor activity of adult rats. (2) 
Systemically administered EEDQ would potentiate the cocaine-induced 
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locomotion of preweanling rats. The latter behavioral effect was presumed to be 
due to an increased percentage of D2High receptors in preweanling rats. To test 
whether EEDQ does, in fact, increase D2 receptor sensitivity a GTPγS assay 
was conduced. GTPγS, which is a measure of receptor/G protein coupling, is one 
of the most common measures of D2 receptor supersensitivity (Geurts, Herman, 
Cumps, & Maloteaux, 1999; Seeman, Battaglia, Corti, Corsi, & Bruno, 2009). (3) I 
hypothesized that EEDQ would increase the Emax and pEC50 values (a measure 
of D2 receptor sensitivity) of preweanling rats, but not adolescent or adult rats. β-
arrestin (ARRB2) and GRK6 regulate DRD2, a super family of G protein receptors 
(Oda et al., 2015). When G-protein phosphorylation is triggered, GRK6 
phosphorylates the receptor while ARRB2 causes internalization of the 
phosphorylated receptors. Importantly, ARRB2 and GRK6 levels should be 
depressed in situations of high D2 receptor sensitivity (Hurle, 2001; Oda et al., 
2015).  (4) For this reason, I hypothesized that EEDQ would decrease ARRB2 



















 Subjects were 432 preweanling, adolescent, and adult rats. Male (N = 96) 
and female (N = 48) adult rats were purchased from Charles River (Hollister, 
CA); whereas, male (N = 96) and female (N = 48) preweanling rats, as well as 
male (N = 96) and female (N = 48) adolescent rats, were born and bred at 
California State University, San Bernardino (CSUSB). Litters were culled to 10 
pups on postnatal day (PD) 3 and weaned on PD 23. Preweanling rats were kept 
with the dam and littermates, whereas adolescent and adult rats were group-
housed with conspecifics. All rats were housed on racks in large polycarbonate 
maternity cages (56 × 34 × 22 cm) with wire lids. Food and water was freely 
available. The colony room was maintained at 22–23 °C and kept under a 12 
L:12 D cycle. Subjects were cared for according to the “Guide for the Care and 
Use of Laboratory Animals” (National Research Council, 2010) under a research 
protocol approved by the Institutional Animal Care and Use Committee of 
CSUSB. 
Apparatus  
 For preweanling (PD 18), adolescent (PD 40), and adult (PD 85) rats, 
behavioral testing was done in activity monitoring chambers that consist of acrylic 
walls, a plastic floor, and an open top (Coulbourn Instruments, Whitehall, PA). 
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Each chamber includes an X–Y photobeam array, with 16 photocells and 
detectors, that was used to determine distance traveled (a measure of locomotor 
activity). In order to equate for differences in body size (see Campbell, Lytle, & 
Fibiger, 1969; Shalaby & Spear, 1980), preweanling rats were tested in smaller 
chambers (26 × 26 × 41 cm) than adolescent and adult rats (41 × 41 × 41 cm).  
Drugs  
 Cocaine was dissolved in saline; whereas, EEDQ was dissolved in a 50% 
DMSO solution [1:1 (v/v) in distilled water]. Drugs were purchased from Sigma 
(St. Louis, MO). Drugs were injected intraperitoneally (IP) at a volume of 2.5 
ml/kg (preweanling rats) and 1 ml/kg (adolescent and adult rats).   
Behavior Procedure 
 
 Prior to the start of behavioral testing, male and female rats were 
randomly assigned to treatment groups. At 24 h prior to testing (i.e., on PD 17, 
PD 39, or PD 84), rats were injected with vehicle or EEDQ (2.5 or 7.5 mg/kg) and 
then returned to their home cage. After 24 h (i.e., on PD 18, PD 40, or PD 85), 
rats (n = 8 per group) were taken to the experimental room and injected with 
saline or 15 mg/kg cocaine immediately before being placed in the testing 
chambers for 120 min. Locomotor activity was measured.  
Homogenate [
35S] GTPγS Binding Assay  
 On PD 17, PD 39, and PD 84, male rats were injected with vehicle or 
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EEDQ  (2.5 or 7.5 mg/kg). After 24 h, rats (n = 8 per group) were killed by rapid 
decapitation and CPu sections were dissected bilaterally on an ice-cold 
dissection plate and stored at -80 °C. On the day of assay, tissue was thawed on 
ice, and crude membrane homogenates were homogenized in 100 volumes of 50 
mM Tris-HCl buffer (pH 7.4) for approximately 20 s using a Brinkman Polytron. 
Homogenates were centrifuged at 20,000 × g for 30 min. The pellet was 
resuspended in 100 volumes of the same buffer and centrifuged again at 20,000 
× g for 30 min. The final pellet was suspended in approximately 20 volumes of 
buffer (pH 7.4) and incubated for 30 min at 30 °C to remove endogenous 
transmitter. Protein concentrations for the final pellet were determined using the 
Bio-Rad Protein Assay with BSA as the standard. 
 Agonist-effect curves of [
35
S] GTPγS binding were performed in assay 
buffer (50 mM Tris-HCl, 120 mM NaCl) containing 30 μM GDP, 10–20 μg protein, 
along with DA (1 nM to 1 mM) or equivalent volumes of water. Nonspecific 
binding was determined in the presence of 30 μM cold GTPγS. The tubes were 
preincubated for 15 min at 30 °C, and then 0.1 nM [
35
S] GTPγS was added. 
Following the addition of [
35
S] GTPγS, tubes were incubated for an additional 30 
min at 30 °C. The incubation period was ended by filtering the contents of the 
tubes using glass fiber filters. Net agonist-stimulated [
35
S] GTPγS binding values 
were calculated by subtracting basal binding values (without agonist) from 
agonist-stimulated values (with agonist) and dividing by basal values. Agonist 
potency (pEC50) and agonist efficacy (Emax) were determined by iterative 
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nonlinear regression fitting using Prism (Graph Pad Software).  
ARRB2 and GRK6 
 On PD 17, PD 39, and PD 84, male rats were injected with vehicle or 
EEDQ (2.5 or 7.5 mg/kg). After 24 h, rats (n = 8 per group) were killed by rapid 
decapitation and CPu sections were dissected bilaterally on an ice-cold 
dissection plate and stored at -80 °C. Frozen CPu sections were weighed and 
sonicated into a 20 nM tris buffer containing 1% NP40 and a protease inhibitor 
cocktail. After sonication, samples were centrifuged at 10,000 × g for 15 min at 4 
°C. Protein concentrations for the final pellet were determined using the Bio-Rad 
Protein Assay with BSA as the standard. 
  ARRB2 and GRK6 were assessed using enzyme-linked immunosorbant 
assay (ELISA) kits (CUSABIO, CBS-EL002135RA and CBS-EL009927RA). 
Briefly, various dilutions of standard ARRB2 or GRK6 were made and test 
samples were diluted in sample diluent (1% BSA, 0.125% Tween-20 in PBS) and 
added to the wells of precoated assays plates. The plates were incubated for 2 h 
at 37 °C. Liquid from each well was discarded and 100 μL of biotin-antibody 
(ARRB2 or GRK6) was added. The plates were incubated at 37 °C for 1 h. Plates 
were aspirated and washed three times with wash buffer (PBS, 0.1%Tween-20), 
after which 100 μL HRP-avidin was added to each well and the plates were again 
be incubated at 37 °C for 1 h. After the incubation, the plates were washed five 
times and TMB substrate was added to each well and incubated at 37 °C for 15-
30 min in the dark. To stop the color development, stop solution was added. To 
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determine optical density values, absorbance readings at 450 nm, with a 
wavelength correction reading at 540 nm, was made using a micro plate reader 
(Multiskan Sky, Thermo Scientific, Waltham, MA).  
Statistical Analyses 
 All main effects, interactions, and post hoc tests were considered 
significant at p<0.05. Litter effects were minimized by assigning no more than 
one rat from each litter to a particular condition (Holson & Pearce, 1992). For the 
behavioral experiment, distance traveled data were analyzed using a repeated 
measures analysis of variance (ANOVA) 3 x 3 x 2 x 12 (age x pretreatment x 
drug x time block). Mauchly’s test was used to detect violations of the sphericity 
assumption. When violations of sphericity were detected the Huynh-Feldt Epsilon 
statistic was used to make corrections. When appropriate, Tukey tests were used 
for making planned and post hoc comparisons. For Tukey calculations involving 
time block interactions, the mean square error term was calculated using 
separate one- or two-way ANOVAs. 
 For the GTPγS binding assay a logarithmic transformation of Emax and 
pEC50 was conducted (Y’=log10Y). GTPγS (Emax and pEC50), ARRB2, and GRK6 
data were analyzed using separate 3 x 3 (age x pretreatment) between-subjects 
ANOVAs. Tukey tests were used for making planned and post hoc comparisons 
(p<0.05).   
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CHAPTER NINE 
BEHAVIORAL RESULTS  
Overall Analysis  
 Overall, female rats exhibited significantly more locomotor activity than 
male rats [Sex main effect, F1,252=27.10, p<.001]. Based on this finding, the 
behavioral data of male and female rats were analyzed separately in the final 
statistical analyses. 
Ontogenetic Differences in the Locomotor Activity of Male Rats  
(Collapsed Over Time Blocks) 
Among male rats, the pre- and posttreatment factors interacted with age to 
affect locomotor activity [Age x Pre x Post interaction, F4,126 = 15.24, p<.001]. In 
saline-treated preweanling rats, EEDQ had no effect on basal locomotor activity; 
however, in adolescent and adult male rats both doses of EEDQ (2.5 and 7.5 
mg/kg) reduced the basal locomotor activity of saline-treated male rats (see left 
graph, Figure 1) [Pretreatment effects, F2,21=18.04, p<.001, F2,21=7.82, p<.001, 
and Tukey tests p<.05, respectively].  
 The pattern of results changed when rats were injected with cocaine.  For 
example, preweanling male rats pretreated with 7.5 mg/kg EEDQ exhibited a 
potentiated locomotor response when injected with cocaine (see upper graphs, 
Figure 1) [Pretreatment effect, F2,21=11.39, p<.001]. A nearly opposite effect 
occurred in adolescent and adult male rats, because 2.5 and 7.5 mg/kg EEDQ 
reduced cocaine-induced locomotor activity (see middle and lower right graphs, 
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Figure 1) [Pretreatment effects, F2,21=17.59, p<.001, F2,21=91.30, p<.001, and 
Tukey tests p<.05, respectively]. 
 A separate statistical analysis comparing the effects of saline and cocaine 
in vehicle-pretreated male rats showed that 15 mg/kg cocaine caused greater 
locomotor activity in adolescent and adult rats than preweanling rats 
[Posttreatment x Age interaction, F2,42=10.82, p<.001, and Tukey tests, p<.05], 
while the basal locomotor activity of saline-treated male rats did not differ 
according to age (compare open bars, Figure 1).The same statistical analysis 
showed that cocaine significantly increased the locomotor activity of adolescent 
and adult rats, but not preweanling rats. Importantly, an ANOVA including only 
preweanling male rats indicated that 15 mg/kg cocaine did, in fact, increase the 
locomotor activity of the younger age group [Posttreatment effect, F1,14 = 22.98, 
p<.001, and Tukey tests, p<.05].  
Ontogenetic Differences in the Locomotor Activity of Male Rats 
 (Time-Dependent Effects) 
 Overall, an omnibus ANOVA showed that age interacted with pretreatment, 
posttreatment, and time variables to affect distance traveled scores [Age × Pre × 
Post interaction, F4,126 =15.24, p<0.001; aAge × Pre × Post × Time Block 
interaction, F19,610 =1.60, p<0.05].  To further break apart the statistically 
significant three- and four-way interactions, separate lower order ANOVAs were 
conducted at each age. 
 Among saline-treated preweanling male rats, EEDQ did not differentially 
affect distance traveled scores across time blocks; however, 7.5 mg/kg EEDQ 
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potentiated the locomotor activity of rats treated with 15 mg/kg cocaine on time 
blocks 5–12 (see upper right graph, Figure 2) [aPre × Post × Time block 
interaction, F13,265 =1.91, p<0.05; and Tukey tests, p<0.05].  Separate analyses of 
saline-treated adolescent male rats indicated that 2.5 mg/kg EEDQ depressed 
locomotion on time blocks 1, 2, 4, and 11; whereas, 7.5 mg/kg EEDQ reduced 
locomotion on time blocks 1–6 and time blocks 10 and 11 (see left middle graph, 
Figure 2) [aPre × Time block interaction, F19,204 =4.51, p<0.001; and Tukey tests, 
p<0.05].  Likewise, 2.5 and 7.5 mg/kg EEDQ decreased the distance traveled of 
cocaine-treated adolescent male rats on all 12 time blocks (see right middle 
graph, Figure 2) [aPre × Time block interaction, F5,53 =3.31, p<0.05; and Tukey 
tests, p<0.05].  Similar to adolescents, 2.5 and 7.5 mg/kg EEDQ decreased the 
distance traveled scores of cocaine-treated adult male rats (time blocks 1–12) 
and saline-treated adult male rats (time blocks 1–3 and time block 7) (see lower 
graphs, Figure 2) [aPre × Post × Time block interaction, F8,158 =3.67, p<0.001; 
and Tukey tests, p<0.05].   
 
 Comparisons across age showed that preweanling male rats in the 
vehicle-saline control group exhibited less locomotor activity than similarly 
treated adolescent (time block 1) and adult male rats (time blocks 1–3 and time 
block 7) (compare left graphs, Figure 2) [aAge × Pre ×Time block interaction, 
F28,351 =2.22, p<0.001; and Tukey tests, p<0.05].  No age differences were 
apparent when EEDQ-pretreated male rats were tested after an injection of 
saline.  When injected with cocaine, vehicle-pretreated adolescent and adult 
male rats had greater distance traveled scores than preweanling male rats on 
time blocks 2–12 (compare right graphs, Figure 2) [aAge × Pre ×Time block 
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interaction, F17,261 =2.20, p<0.01; and Tukey tests, p<0.05].  Conversely, cocaine-
treated preweanling male rats injected with 7.5 mg/kg EEDQ had greater 
distance traveled scores than similarly treated adult male rats on time blocks 1–
12 and similarly treated adolescent male rats on time blocks 6–12 (Tukey tests, 
p<0.05).   
Ontogenetic Differences in the Locomotor Activity of Female Rats  
(Collapsed Over Time Blocks) 
Among female rats, the pre- and posttreatment factors interacted with age 
to affect locomotor activity [Age x Pre x Post interaction, F4,126 = 6.68, p<.001]. In 
female preweanling rats treated with saline, EEDQ caused a significant increase 
in basal locomotor activity (see upper right graph, Figure 3) [Pre effect, 
F2,21=16.38, p<.001, and Tukey tests, p<.05]. However, in adolescent and adult 
female rats, both doses of EEDQ (2.5 and 7.5 mg/kg) decreased locomotor 
activity of saline-treated rats (see middle and lower right graphs, Figure 3) [Pre 
effects, F2,21=14.22, p<.001, F2,21=31.44, p<.001, and Tukey tests, p<.05, 
respectively]. 
 Results changed when female rats were injected with cocaine. In 
preweanling female rats, 7.5 mg/kg EEDQ caused a marginally significant 
increase in the locomotor activity of cocaine-treated rats (see upper right graph, 
Figure 3) [Pre effect, F2,21=3.40, p<.052, and Tukey tests, p<.05]. However, in 
adolescent and adult female rats both doses of EEDQ significantly decreased 
cocaine-induced locomotor activity (see middle and lower right graphs, Figure 3) 
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[Pre effects, F2,21=50.38, p<.001, F2,23=22.92, p<.001, and Tukey tests, p<.05, 
respectively]. 
 As was done with male rats, a separate ANOVA comparing the effects of 
saline and cocaine in vehicle-pretreated female rats was conducted. Adolescent 
and adult female rats given 15 mg/kg cocaine exhibited greater locomotor activity 
than preweanling female rats [Posttreatment x Age interaction, F2,42=10.26, 
p<.001, and Tukey tests, p<.05]. In addition, cocaine-treated female rats of all 
ages exhibited significantly greater distance traveled scores than saline-treated 
female rats of the same age [Tukey test, p<.05].  
Ontogenetic Differences in the Locomotor Activity of Female Rats 
 (Time-Dependent Effects) 
 
 Overall, an omnibus ANOVA showed that age interacted with pretreatment, 
posttreatment, and time variables to affect distance traveled scores [Age × Pre × 
Post interaction, F4,126 =6.68, p<0.001; aAge × Pre × Post × Time Block 
interaction, F19,610 =1.49, p<0.05].  To further break apart the statistically 
significant three- and four-way interactions, separate lower order ANOVAs were 
conducted at each age. 
 Among saline-treated preweanling female rats, 7.5 mg/kg EEDQ 
increased locomotion on time blocks 2-8, 10 and 11 (see upper left graph, Figure 
4) [aPre × Time block interaction, F19,204 =1.13, p<0.001; and Tukey tests, 
p<0.05]. Moreover, 7.5 mg/kg EEDQ potentiated the locomotor activity of female 
rats treated with 15 mg/kg cocaine on time blocks 6, 7, 9-12 (see upper right 
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graph, Figure 4) [aPre × Post × Time block interaction, F13,265 =3.98, p<0.05; and 
Tukey tests, p<0.05].   
 Separate analyses of saline-treated adolescent female rats indicated that 
2.5 and 7.5 mg/kg EEDQ depressed locomotion on time blocks 1-4, 6, 7, 9, 10 
and 12 (see left upper graph, Figure 4) [aPre × Time block interaction, F19,204 
=2.58, p<0.001; and Tukey tests, p<0.05].  EEDQ at both doses (2.5 and 7.5 
mg/kg) decreased the distance traveled scores of cocaine (time blocks 1–12) and 
saline (time blocks 1–5 and time block 7-11) treated adult female rats (see lower 
graphs, Figure 4) [aPre × Post × Time block interaction, F8,158 =4.31, p<0.001; 
and Tukey tests, p<0.05].   
 Comparisons across age showed that female rats in the vehicle-saline 
control group exhibited an increase in locomotor activity with aging increase.  
Adolescent (time block 1-4, 6, 7, 9, 10, and 12) and adult (time blocks 1–5 and 7-
11) female rats had more locomotor activity than preweanling rats (compare left 
graphs, Figure 4)  [aPre ×Time block interaction, F28,351 =5.13, p<0.001; and 
Tukey tests, p<0.05]. There were significant age differences when EEDQ (7.5 
mg/kg)-pretreated female rats were tested after an injection of cocaine. 
Specifically, cocaine-treated preweanling rats exhibited more locomotor activity 
than adolescent and adults female rats on time block 6, 7, and 9-12 [aPre ×Time 
block interaction, F28,351 =7.41, p<0.001; and Tukey tests, p<0.05].  
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[35S]GTPγS Binding  
 GTPγS binding was significantly greater in preweanling rats than adults 
(Table 1) [Age main effect, F2,54=3.98, p<0.05; and Tukey tests, p<0.05].  Both 
doses of EEDQ (2.5 and 7.5 mg/kg) increased Emax values [Drug main effect, 
F2,54=15.54, p<0.001; and Tukey tests, p<0.05]. The efficacy of GTPγS binding of 
EEDQ-treated preweanling rats was greater than either vehicle-treated 
preweanling rats or EEDQ-treated adult rats [Age × Pretreatment interaction, 
F2,57=3.81; p<0.05, and Tukey tests, p<0.05].  EEDQ also increased Emax values 
of adolescent rats relative to same-age vehicle controls [Tukey tests, p<0.05]. 
pEC50 binding did not vary according to age or pretreatment condition (Table 2).  
ARRB2 Levels  
Both doses of EEDQ (2.5 and 7.5 mg/kg) reduced ARRB2 levels [Pretreatment 
main effect, F2,86=5.92, p<0.05; and Tukey tests, p<0.05]. There were age 
differences in which AARB2 levels increased with age. Specifically, adults had 
the highest levels of ARRB2, preweanling rats had the lowest levels, and 
adolescent rats had moderate levels of ARRB2 that were significantly different 
from both younger and older rats [Age main effect, F2,86=75.28, p<0.001; and 
Tukey tests, p<0.05].  The Age × Pretreatment interaction was not statistically 
significant [p=0.21]. 
GRK6 Levels  
EEDQ did not affect GRK6 levels. Adult rats had significantly greater GRK6 
levels than both of the younger age groups [Age main effect, F2,86=72.25, 






























































































Figure 1. Ontogenetic Differences in the Locomotor Activity of Male Rats 
(Collapsed Over Time Blocks) 
 
Mean (SEM) distance traveled scores of preweanling, adolescent, and adult 
male rats (n = 8 rats per group) injected with saline or cocaine (15 mg/kg, IP) 
immediately before testing.  On the pretreatment day, which occurred 24 h 
earlier, rats had been injected with vehicle or EEDQ (2.5 or 7.5 mg/kg, IP). 
 
‘a’ indicates a significant difference from vehicle-treated rats of the same age given the same post 
injection (i. e., saline or cocaine). ‘b’ indicates a significant difference from cocaine-treated 
adolescent and adult rats that were pretreated with vehicle. ‘c’ indicates a significant difference 
























































































Figure 2. Ontogenetic Differences in the Locomotor Activity of Male Rats (Time-
Dependent Effects) 
 
Mean (SEM) distance traveled scores of preweanling, adolescent, and adult 
male rats (n = 8 rats per group) injected with saline or cocaine (15 mg/kg, IP) 
immediately before testing.  On the pretreatment day, which occurred 24 h 

































































































Figure 3. Ontogenetic Differences in the Locomotor Activity of Female Rats 
(Collapsed Over Time Blocks) 
 
Mean (SEM) distance traveled scores of preweanling, adolescent, and adult 
male rats (n = 8 rats per group) injected with saline or cocaine (15 mg/kg, IP) 
immediately before testing.  On the pretreatment day, which occurred 24 h 
earlier, rats had been injected with vehicle or EEDQ (2.5 or 7.5 mg/kg, IP). 
 
‘a’ indicates a significant difference from vehicle-treated rats of the same age given the same post 
injection (i. e., saline or cocaine). ‘b’ indicates a significant difference from cocaine-treated 
adolescent and adult rats that were pretreated with vehicle. ‘c’ indicates a significant difference 






















































































Figure 4. Ontogenetic Differences in the Locomotor Activity of Female Rats 
(Time-Dependent Effects) 
 
Mean (SEM) distance traveled scores of preweanling, adolescent, and adult 
female rats (n = 8 rats per group) injected with saline or cocaine (15 mg/kg, IP) 
immediately before testing.  On the pretreatment day, which occurred 24 h 







Table 1. Mean (SEM) Efficacy (Emax) of NPA-Stimulated [35S]GTPγS Specific 
Binding in the Dorsal Striatum of EEDQ-Treated Preweanling, Adolescent, and 
Adult rats (n = 7 per group)  
  
 
Pretreatment                Age       
________________________________________________ 
  
  Preweanling  Adolescent  Adult  x̅(P+A+A) 
    
 
Vehicle  13.21 (2.30)      16.47 (2.76)        16.02 (1.16)     15.23 (1.24) 
 
2.5 mg/kg EEDQ  40.76 (5.36) cd 28.04 (3.84) e    22.33 (2.92)    30.38(2.86) b 
 
7.5 mg/kg EEDQ   37.12 (6.94) cd 29.51 (3.06) e    26.07 (3.71)    30.90(2.86) b 
 
x̅ (V+E+E) 30.36 (3.96) a 24.68 (2.21)     21.47 (1.80) 
________________________________________________________________ 
 
‘a’ Significantly different from adult rats [Tukey tests, p < 0.05].   
 
‘b’ Significantly different from vehicle-treated rats [Tukey tests, p < 0.05].   
 
‘c’ Significantly different from vehicle-treated preweanling rats [Tukey tests, p < 0.05].   
 
‘d’ Significantly different from EEDQ-treated adult rats [Tukey tests, p < 0.05].   










Table 2.  Mean (SEM) Potency (pEC50) of NPA-Stimulated [35S]GTPγS Specific 
Binding in the Dorsal Striatum of EEDQ-Treated Preweanling, Adolescent, and 
Adult Rats (n = 7 per group) 
  
 
Pretreatment                Age       
________________________________________________ 
  
  Preweanling  Adolescent  Adult  x̅(P+A+A) 
    
 
Vehicle  6.93 (0.33) 6.63 (0.51)      6.04 (0.29)        6.74 (0.18) 
 
2.5 mg/kg EEDQ  6.54 (0.42) 6.01 (0.42)      6.97 (0.52)        6.37 (0.22) 
   
7.5 mg/kg EEDQ   6.74 (0.13) 6.46 (0.36)      6.05 (0.42)        6.35 (0.26) 
 






Table 3. Mean (SEM) -Arrestin-2 Levels (pg/mg protein) in the Dorsal Striatum 




Pretreatment                Age       
________________________________________________ 
  
  Preweanling  Adolescent  Adult  x̅(P+A+A) 
    
 
Vehicle  577.1 (54.2) 915.2 (59.5)    1223.3 (75.9)   925.0 (60.4) 
 
2.5 mg/kg EEDQ  476.7 (46.6) 858.7 (49.2)    1015.4 (44.8)  778.4 (49.0) a 
 
7.5 mg/kg EEDQ   526.8 (54.6) 831.1 (39.0)    944.6 (33.8)    754.8 (40.3) a 
 
x̅ (V+E+E) 526.8 (30.2) bc 866.9 (28.2) b  1073.0 (39.8) 
_______________________________________________________________ 
 
‘a’ Significantly different from vehicle-treated rats [Tukey tests, p < 0.05].   
 
‘b’ Significantly different from adult rats [Tukey tests, p < 0.05].   
 
‘c’ Significantly different from adolescent rats [Tukey tests, p < 0.05].   
 





















Table 4. Mean (SEM) GRK6 Levels (pg/mg protein) in the Dorsal Striatum of 
EEDQ-Treated Preweanling, Adolescent, and Adult Rats (n = 10–12 per group)  
  
 
Pretreatment                Age       
________________________________________________ 
  
  Preweanling  Adolescent  Adult  x̅(P+A+A) 
    
 
Vehicle  342.6 (36.7) 620.9 (35.4)       758.6 (54.7)    585.6 (40.0) 
  
2.5 mg/kg EEDQ  337.6 (19.2) 628.9 (15.2) 686.4 (46.6)    551.0 (33.0)  
 
7.5 mg/kg EEDQ   372.6 (27.2) 624.8 (35.2) 669.7 (45.8)    546.7 (30.8)  
 
x̅ (V+E+E) 352.3 (16.2) ab 624.9 (17.0) a 708.3 (28.9) 
 
‘a’ Significantly different from adult rats [Tukey tests, p < 0.05].   
 

















Behavioral Effects of EEDQ 
 It is well established that EEDQ attenuates locomotor activity in adult rats 
by reducing the amount of D2 receptors available (Der-Ghazarian et al., 2014; 
McDougall et al., 2015). In adolescent rats, the EEDQ-induced reduction in 
locomotor activity is similar to the decline observed in adult rats (McDougall et 
al., 2014). In preweanling rats, EEDQ also inactivates D2 receptors in the dorsal 
striatum; however, DA agonists cause a potentiated locomotor response 
(McDougall et al., 1993). An important goal of the present study was to determine 
what DA receptor changes are responsible for the different locomotor effects 
observed in EEDQ-treated rats across ontogeny.  
Age-Dependent Behavioral Differences  
 In the present thesis, 15 mg/kg cocaine produced a statistically significant, 
but small, increase in the locomotor activity of PD 18 rats; however, 15 mg/kg 
cocaine caused a large increase in the locomotor activity of adolescent and adult 
rats. Regardless of age, cocaine produced a slightly greater locomotor response 
in female rats than male rats. Basal locomotor activity of preweanling rats was 
reduced relative to female and male saline-treated adolescent and adult rats. 
 Rats treated with saline prior to EEDQ exhibited substantially different 
amounts of locomotor activity depending on age. Saline-treated female 
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preweanling rats injected with EEDQ showed an increase in locomotor activity on 
the test day, while saline-treated female adolescent and adult rats injected with 
EEDQ exhibited a decline in locomotor activity on the test day. On the other 
hand, basal locomotor activity of male preweanling rats was not affected by 
EEDQ, even though saline-treated adolescent and adult male rats showed a 
significant reduction in locomotion after EEDQ treatment. 
 EEDQ also differentially affected cocaine-induced locomotor activity 
depending on age. Preweanling male rats treated with cocaine exhibited a 
potentiated locomotor response after EEDQ treatment. In stark contrast, adult 
and adolescent rats showed the opposite effect, as EEDQ attenuated cocaine-
induced locomotor activity. Likewise, female preweanling rats treated with either 
dose of EEDQ (2.5 or 7.5 mg/kg) exhibited a potentiated locomotor response 
when injected with cocaine. Both doses of EEDQ reduced the cocaine-induced 
locomotor activity of female adolescent and adult rats. 
 In sum, EEDQ pretreatment (2.5 and 7.5 mg/kg) impacted locomotor 
behavior across ontogeny. Among preweanling rats, both doses of EEDQ 
increased the locomotor activity of cocaine-treated rats. Adolescent rats showed 
a significant reduction of locomotor activity after EEDQ treatment, although 
cocaine-treated adolescent rats exhibited a slight increase in distance traveled 
scores when compared to saline-treated rats. Adult rats showed a similar pattern 
of behavior as adolescent rats, since both doses of EEDQ (2.5 and 7.5 mg/kg) 
reduced locomotor activity in cocaine-treated adults. 
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Neurochemistry Results Pertaining to DA Supersensitivity 
  It was originally hypothesized that the increase in locomotor activity 
evident in EEDQ-treated preweanling rats is due to DA receptor supersensitivity. 
To assess this hypothesis we measured GTPγS binding, as well as ARRB2 and 
GRK6 content, because DA receptor supersensitivity is reliably associated with 
increased GTPγS binding and decreased ARRB2 and GRK6 levels (Oda et al., 
2015). Moreover, it has been established that GTPϒS binding is positively 
correlated with the percentage of D2 receptors in a high affinity state (Seeman et 
al., 2009). In the present thesis, EEDQ increased the GTPϒS binding of 
preweanling rats, thus suggesting that EEDQ-treated rats had an excess of 
D2High receptors. Adolescent and adult rats did not exhibit a similar increase in 
GTPγS binding.  
 ARRB2 levels were also used to examine DA supersensitivity in EEDQ-
treated rats, because a decrease in ARRB2 and GRK6 levels indicates 
supersensitivity (Hurle, 2001; Oda et al., 2015). The mechanism for this effect 
has been established, as activation of the D2 receptor causes GRK6 to 
phosphorylate the receptor, which, in turn, stimulates ARRB2 to bind with the G 
protein/receptor complex (Del’Guidice, Lemasson, & Beaulieu, 2011; Porter-
Stransky & Weinshenker, 2017). ARRB2 binding causes internalization of the 
ligand-bound receptor, and a loss of receptor sensitivity, until the receptor is 
dephosphorylated (for reviews, see Gainetdinov et al., 2017). In the present 
study, ARRB2 levels increased with age. More importantly, EEDQ-treated rats, 
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regardless of age, had reduced levels of ARRB2 when compared to saline-
treated rats. This decline in ARRB2 levels indicated that EEDQ caused D2 
receptor supersensitivity.  
 GRK6 levels were not significantly affected by EEDQ treatment at any 
age. Although it was originally hypothesized that GRK6 levels would be reduced 
in EEDQ-treated preweanling rats, the current results did not show such an 
effect. Instead, GRK6 levels were elevated in adult rats relative to the younger 
age groups. In sum, the EEDQ-induced increase in GTPγS binding and decrease 
in ARRB2 levels are consistent with a DA supersensitivity explanation, whereas 
the GRK6 data are not supportive. 
Explanations of EEDQ-Induced Locomotor Potentiation in Preweanling Rats 
 The working hypothesis on which this thesis was based is that EEDQ 
destroys a significant percentage of D2 receptors in preweanling rats, but that the 
remaining D2 receptors are in a high affinity state. It is these surviving D2 
receptors that we believe are responsible for the potentiated locomotor response 
exhibited by EEDQ-treated preweanling rats.  
 Alternative explanations are available for the paradoxical cocaine-induced 
locomotor responding of EEDQ-treated preweanling rats. First, EEDQ may not 
cause DA receptor loss in preweanling rats. This potential explanation is not 
accurate because EEDQ-treated preweanling rats exhibit a 69% reduction of 
dorsal striatal D2 receptors, while adults show a 80% reduction (Crawford et al., 
1992; Crawford, Rowlett, McDougall, & Bardo, 1994; Der-Ghazarian et al., 2012). 
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Although EEDQ causes a greater reduction in the percentage of D2 receptors in 
adult rats, a 61% decline in the number of D2 receptors can certainly not explain 
why EEDQ potentiates the cocaine-induced locomotor activity of preweanling 
rats. 
 Second, these behavioral results could be explained by a large D2 
receptor reserve existing in younger rats. This explanation postulates that some 
DA receptors were inactivated by EEDQ, but an excess of spare D2 receptors 
make EEDQ’s receptor inactivating effects irrelevant (Der-Ghazarian et al., 
2012). Although there is a D1 receptor reserve in adult rats (Meller et 
al.,1985,1987; Rosengarten et al., 1989) there is no evidence that a D2 receptor 
reserve exists in younger rats. In fact, available evidence suggests that a D2 
receptor reserve is not present at any age (Meller, Goldstein, Friedhoff, & 
Schweitzer, 1988).  
 Third, we come back to our original hypothesis that in preweanling rats, 
and perhaps adults, EEDQ inactivates a significant number of D2 receptors, but 
the remaining receptors exist in a high affinity state. Consistent with this idea,  
EEDQ-treated preweanling rats had a greater percentage of D2High receptors 
than EEDQ-treated adolescent and adult rats. The supersensitivity explanation is 
further supported by results from the present thesis in which EEDQ-treated 
preweanling rats had increased GTPγS binding and reduced ARRB2 levels. The 
reason why EEDQ only potentiates the cocaine-induced locomotor activity of 
preweanling rats, and not adolescent and adult rats, is uncertain; however, it is 
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probably because EEDQ inactivates a lesser percentage of D2 receptors in 
younger rats (Crawford et al., 1992; Der-Ghazarian et al., 2014; Leff, Gariano, & 
Creese, 1984) and/or D2 receptors repopulate more quickly in younger rats than 
adults (Kula, George, & Baldessarini, 1992; Leff et al., 1984).  
Differential Effects of EEDQ on Cocaine- and Amphetamine-Induced Locomotor 
Activity 
 
 An interesting aspect of the present study is that EEDQ potentiated the 
cocaine-induced locomotor activity of preweanling rats (Figures 1 and 3), even 
though we previously reported that EEDQ is unable to block amphetamine-
induced locomotor activity in the same age group (Crawford, McDougall, & 
Bardo, 1994a). Two possibilities suggest themselves: (1) Cocaine and 
amphetamine have differing affinities for the DA and 5-HT transporter, and (2) 
cocaine and amphetamine rely on different DA pools. Cocaine has a high affinity 
for the DA, 5-HT, and noradrenergic transporters, while amphetamine and 
methamphetamine only bind to the 5-HT and noradrenergic transporters (Howell 
& Kimmel, 2008). This dichotomy suggests that 5-HT may contribute to the 
locomotor potentiation effect observed in preweanling rats. Consistent with this 
explanation, EEDQ inactivates 5-HT receptors (Kettle, Cheetham, Martin, Prow, 
& Heal, 1999), and some 5-HT receptor subtypes mediate locomotor activity 
(Geyer, 1996).  
 Perhaps of more relevance, cocaine increases extracellular DA by 
blocking re-uptake of DA from vesicular stores, while amphetamine primarily 
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relies on releasing newly synthesized DA from cytosolic pools (Kuczenski, 1983).  
Thus, EEDQ may only attenuate locomotor activity if the indirect DA agonist 
utilizes newly synthesized DA from cytosolic pools. This hypothesis is supported 
by a series of studies showing that EEDQ dramatically reduces the amount of DA 
in cytosolic pools (Crawford et al., 1992; Crawford, McDougall, & Bardo, 1994b). 
In sum, it is possible that the different behavioral actions of amphetamine and 
cocaine are a consequence of the DA pools each drug relies on. 
 
Ontogeny of Drug Action 
 In a broader context, EEDQ is one of many compounds (in multiple drug 
classes) that produce different behavioral effects across ontogeny (Andersen, 
2003, 2005; Spear, 2000). It is likely that maturational changes in DA systems, 
as well as other neurotransmitter systems, underlie age-dependent differences in 
drug action. For example, various components of the DA system, including DA 
content, VMAT2, and plasma membrane DA transporters, show a progressive 
increase from birth into adulthood (Broaddus & Bennett, 1990; Kuperstein et al., 
2008). Moreover, D2 receptors increase from birth until the end of the 
preweanling period, are dramatically overproduced during adolescence, and then 
decline until adulthood age is reached (Rao et al., 1991; Teicher et al., 1995). 
Consistent with these maturational changes, we found that dorsal striatal ARRB2 
and GRK6 levels also increase across ontogeny. Anderson and Teicher (2000) 
have proposed that the transient overproduction of D2 receptors may be of 
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clinical importance for both ADHD and schizophrenia. Our current results may 
also be of clinical relevance, because GRK6 and ARRB2, which are associated 
with D2High receptors, show maturational changes across early ontogeny.  
Sex-Dependent Behavioral Differences  
 Although not a novel finding, cocaine-treated adolescent and adult female 
rats displayed greater locomotor activity than cocaine-treated male rats of the 
same age (Der-Ghazarian et al., 2012; Festa et al., 2004; McDougall et al, 2015; 
Schindler & Carmona, 2002). The behavioral differences between cocaine-
treated males and female rats is probably not related to cocaine 
pharmacokinetics as peak cocaine values and cocaine half-life in brain vary 
minimally according to sex (McDougall et al., 2018; Schindler & Carmona, 2002). 
That being said, there are some active metabolites that differ between the sexes, 
as cocaine-treated female rats have higher levels of ecgonine methyl ester and 
benzoylecgonine than males (Schindler & Carmona, 2002). Whether these small 
differences in metabolite levels can account for sex-dependent changes in 
cocaine responsitivity is uncertain. 
 Another explanation that might account for sex-related differences in 
cocaine’s actions involve gonadal hormones (Becker, 1999). Specifically, 
increased estrogen levels might be responsible for differences in cocaine 
sensitivity. At least two neuronal mechanisms could underlie this effect. First, 
estrogen inhibits GABA which, in turn, increases DA neurotransmission (Becker, 
1999; Schindler & Carmona, 2002). Second, estrogen increases DA release by 
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down-regulating D2 receptor function (Bazzett & Becker, 1994). Males do not 
produce as much estrogen as females; therefore, these two estrogen-based 
mechanisms may explain why cocaine’s behavioral effects are more pronounced 
in female rats (Becker, 1999).  
 In the present study, cocaine also caused a slight increase in the 
locomotor activity of female preweanling rats relative to male rats. This result was 
unexpected and is not consistent with many past studies showing that 
psychostimulants do not differentially affect the locomotor responsiveness of 
prepubertal male and female rats (Kozanian, Gutierrez, Mohd-Yusof, & 
McDougall, 2012; McDougall et al., 2015, 2018; Snyder, Katovic, & Spear, 1998). 
These results are also not consistent with the estrogen explanations just 
discussed, since the gonadal hormone levels of prepubescent rats do not differ 
according to sex. 
Summary 
  DA dysfunction is responsible for many neuropsychiatric problems like 
anorexia, insomnia, aggravation, ADHD, Tourette’s disorder, and psychosis 
(Kostrzewa et al., 2018; Tatsumi, Groshan, Blakely, & Richelson, 1997). Many of 
these disorders are prominent or are initially expressed during early ontogeny 
(Kostrzewa et al., 2018). Adolescence is a crucial developmental period with a 
unique pattern of increased DA activity in response to drugs (Spear, 2000); 
whereas, the late preweanling period is analogous to late childhood, which is a 
time that many DA-mediated disorders are first expressed (Smith & Morrell, 
 52 
2008).  DA supersensitivity, which was a primary focus of this study, varies 
across ontogeny, but appears to be especially pronounced during the 
preweanling period. Accumulating evidence suggests that DA supersensitivity 
may be related to an excess of D2High receptors (Seeman et al., 2009). The 
consequences of excess D2High receptors are many, as D2High receptors may be 
the critical mediating factor leading to psychosis (Seeman et al., 2005). Not only 
do individuals with schizophrenia have an excess of D2High receptors, they also 
show greater sensitivity to DA (Seeman et al., 2005).  When considered together, 
the present behavioral and neurochemical results suggest that DA 
supersensitivity is especially pronounced during the preweanling period, which is 
consistent with the onset of many neuropsychiatric disorders (Tourette’s disorder, 
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